Key Clinical Trials

BAXTER_88081
The purpose of this study is to evaluate the efficacy, safety and consistency of manufacture of three seperate lots of inactivated RRV vaccine.

COHEREX
A study to assess if the new Coherex Left Atrial Appendage Occlusion System is safe and effective.

DECIDE
A study to compare a new treatment with Avonex in preventing relapse in patients with MS.

ENABLE
A study to assess the safety and tolerability and to collect information on how long-term use of prolonged-release Fampridine may affect quality of life and performance of daily activities in patients with Multiple Sclerosis.

SNAC II
This study is and extension to SNAC I and will expand the inclusion to women who have larger breast cancers and more than one breast cancer.

STABILITY
This new study drug will assess people who have had a heart attack and aims to reduce a reoccurrence.

THERAVIDA OVERACTIVE BLADDER
This study investigates the effects and safety of a new medication on symptoms of an overactive bladder.

For a complete list of current clinical trials contact the Clinical Trials Centre on 07 3721 1523.